Background
Rigorous processes ensure quality of research and clinical care at NCI-designated Comprehensive Cancer Centers (NCICCC). Un-measurable elements of structure and process of cancer care delivery warrant evaluation. Impact of NCICCC care on survival and access to NCICCCs for vulnerable subpopulations remains unstudied.
Methods
Our population-based cohort of 69,579 patients had newly-diagnosed adult-onset (22–65 years) cancers reported to the Los Angeles County (LAC) cancer registry between 1998 and 2008. Geographic Information Systems was used for geospatial analysis.
Results
Overall Survival
Across multiple diagnoses, patients not receiving their first planned treatment at NCICCCs experienced poorer outcome compared to those treated at NCICCCs; differences persisted in multivariable analyses adjusting for clinical and sociodemographic factors (hepatobiliary [HR=1.5, 95%CI, 1.4–1.7, p<0.001]; lung [HR=1.4, 95%CI, 1.3–1.6, p<0.001]; pancreatic [HR=1.5, 95%CI, 1.3–1.7, p<0.001]; gastric [HR=1.3, 95%CI, 1.1–1.7, p=0.01]; oral [HR=1.2, 95%CI, 1.0–1.5, p=0.09]; breast [HR=1.3, 95%CI, 1.1–1.5, p<0.001]; and colorectal [HR=1.2, 95%CI, 1.0–1.4, p=0.05).
Barriers to care
Multivariable analyses revealed that a lower likelihood of treatment at NCICCCs was associated with: race/ethnicity (African-American: OR range across diagnoses: 0.4–0.7, p≤0.03; Hispanic: OR, 0.5–0.7, p≤0.04); lack of private insurance (public: OR, 0.6–0.8, p≤0.004; uninsured: OR, 0.1–0.5, p≤0.04); less than high SES (high-mid: OR, 0.4–0.7, p≤0.02; mid: OR, 0.3–0.5, p≤0.001; low: OR, 0.2–0.6, p≤0.01) and residing >9 miles from nearest NCICCC (OR 0.5–0.7, p≤0.02).
Conclusions
Among 22 to 65 year-olds with newly-diagnosed adult-onset cancer, LAC patients treated at NCICCCs experienced superior survival compared with those at non-NCICCC facilities. Barriers to care at NCICCCs included race/ethnicity, insurance, SES and distance.